|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.43 EUR | -0.35% |
|
-0.69% | +31.19% |
| Mar. 20 | Geneuro SA Announces Appointments of Board of Directors | CI |
| Feb. 02 | GeNeuro: share price falls after private placement | CF |
GeNeuro SA reported earnings results for the half year ended June 30, 2022. For the half year, the company reported net loss was EUR 5.68 million compared to EUR 3.4 million a year ago. Basic loss per share from continuing operations was EUR 0.25 compared to EUR 0.17 a year ago.
Diluted loss per share from continuing operations was EUR 0.25 compared to EUR 0.17 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +31.19% | 45.21M | |
| +3.13% | 42.11B | |
| +48.83% | 40.08B | |
| +8.49% | 40B | |
| -10.82% | 26.87B | |
| +8.26% | 24.58B | |
| -23.69% | 18.44B | |
| +1.58% | 11.94B | |
| +32.83% | 11.66B | |
| +6.63% | 11.01B |
GENEURO SA 
